The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers
Open accessAbstract
Nanometric biocompatible Metal-Organic Frameworks (nanoMOFs) are promising candidates for drug delivery. Up to now, most studies have targeted the intravenous route, related to pain and severe complications; whereas nanoMOFs for oral administration, a commonly used non-invasive and simpler route, remains however unexplored. We propose here the biofriendly preparation of a suitable oral nanocarrier based on the benchmarked biocompatible mesoporous iron(III) trimesate nanoparticles coated with the bioadhesive polysaccharide chitosan (CS). This method does not hamper the textural/structural properties and the sorption/release abilities of the nanoMOFs upon surface engineering. The interaction between the CS and the nanoparticles has been characterized through a combination of high resolution soft X-ray absorption and computing simulation, while the positive impact of the coating on the colloidal and chemical stability under oral simulated conditions is here demonstrated. Finally, the intestinal barrier bypass capability and biocompatibility of CS-coated nanoMOF have been assessed in vitro, leading to an increased intestinal permeability with respect to the non-coated material, maintaining an optimal biocompatibility. In conclusion, the preservation of the interesting physicochemical features of the CS-coated nanoMOF and their adapted colloidal stability and progressive biodegradation, together with their improved intestinal barrier bypass, make these nanoparticles a promising oral nanocarrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
Cited by
Metal–Organic Frameworks for Drug Delivery: A Design Perspective
Lawson, H. D., Walton, S. P., & Chan, C. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c01089 · Cited by 916
Metal-organic frameworks for advanced drug delivery
He, S., Wu, L., Li, X., Sun, H., Xiong, T., Liu, J., Huang, C., Xu, H., Sun, H., Chen, W., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.019 · Cited by 528
Enzyme‐MOF Nanoreactor Activates Nontoxic Paracetamol for Cancer Therapy
Lian, X., Huang, Y., Zhu, Y., Fang, Y., Zhao, R., Joseph, E., Li, J., Pellois, J., & Zhou, H. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201801378 · Cited by 283
MOFs and bone: application of MOFs in bone tissue engineering and bone diseases
Li, X., Shu, X., Shi, Y., Li, H., & Pei, X. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.107986 · Cited by 65
Mokri, N., Sepehri, Z., Faninam, F., Khaleghi, S., Kazemi, N. M., & Hashemi, M. (2022) · Gene Therapy · doi:10.1038/s41434-021-00265-7 · Cited by 36
Metadata
- Authors
- Hidalgo, T., Giménez-Marqués, M., Bellido, E., Avila, J., Asensio, M. C., Salles, F., Lozano, M. V., Guillevic, M., Simón-Vázquez, R., González-Fernández, A., Serre, C., Alonso, M. J., & Horcajada, P.
- Venue
- Scientific Reports
- Published
- 2017-03-03
- Volume
- 7
- Issue
- 1
- Pages
- 43099-43099
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2594317240
- Cited by
- 173
- References
- 2
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers. https://app.cochat.ai/papers/10.1038/srep43099
- The paper
- Hidalgo, T., Giménez-Marqués, M., Bellido, E., Avila, J., Asensio, M. C., Salles, F., Lozano, M. V., Guillevic, M., Simón-Vázquez, R., González-Fernández, A., Serre, C., Alonso, M. J., & Horcajada, P. (2017). Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers. Scientific Reports. https://doi.org/10.1038/srep43099
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.